Table 2 Poststroke rehabilitation (RHB) characteristics at the baseline visit.
NO IRT1 (n = 17) | IRT1 (n = 45) | p value2 | ||
|---|---|---|---|---|
Inpatient rehabilitation | 100 (17) | 95.6 (43) | 1 | |
Day-hospital rehabilitation | 0 (0) | 4.4 (2) | 1 | |
Time stroke- RHB (days) | 11 (8, 14) | 14 (9, 19) | 0.09 | |
Time stroke-sample (days) | 10 (6, 13.5) | 14 (8.2, 19) | 0.08 | |
RHB hour/week, baseline | 7.5 (5, 9) | 15 (15, 16) | < 0.01 | |
Functional scores | ||||
mRS | 5 (3.2, 5) | 4 (3, 5) | 0.2 | |
BI | 23 (20, 36.5) | 35 (20, 68) | 0.12 | |
CAHAI | 18.5 (13, 82) | 13 (13, 16) | 0.02 | |
FMA | 9 (0, 59) | 8.5 (4, 40.7) | 0.94 | |
FAC | 0 (0, 2.7) | 0 (0, 2) | 0.78 | |
MRC proximal upper limbs | 2.5 (0, 3) | 2 (0, 4) | 0.99 | |
MRC distal upper limbs | 0.5 (0, 3.5) | 1 (0, 4) | 0.95 | |
MRC proximal lower limbs | 3 (2, 4) | 2 (1, 4) | 0.98 | |
MRC distal lower limbs | 1 (0, 3) | 1 (0, 4) | 0.34 | |
Biomarker level | ||||
Endostatin ng/mL | 139 (117, 180) | 132 (111, 162) | 0.61 | |
GDF-10 pg/mL | 1211 (815, 1752) | 1385 (888, 1951) | 0.63 | |
Human uPA pg/mL | 566 (459, 630) | 618 (481, 734) | 0.11 | |
Human uPAR pg/mL | 2668 (2112, 2944) | 2819 (2449, 3434) | 0.21 | |
